Content area
Title
Retraction Note: DNA-PK inhibition synergizes with oncolytic virus M1 by inhibiting antiviral response and potentiating DNA damage
Author
Xiao, Xiao 1 ; Liang, Jiankai 2 ; Huang, Chunlong 3 ; Li, Kai 4 ; Xing, Fan 5 ; Zhu, Wenbo 2 ; Lin, Ziqing 6 ; Xu, Wencang 6 ; Wu, Guangen 6 ; Zhang, Jifu 6 ; Lin, Xi 7 ; Tan, Yaqian 2 ; Cai, Jing 2 ; Hu, Jun 8 ; Chen, Xueqin 9 ; Huang, Youwei 9 ; Qin, Zixi 9 ; Qiu, Pengxin 2 ; Su, Xingwen 2 ; Chen, Lijun 2 ; Lin, Yuan 10 ; Zhang, Haipeng 7 ; Yan, Guangmei 2
1 Institute of Clinical Medicine, The First Affiliated Hospital, University of South China, 421001, Hengyang, China (ROR: https://ror.org/03mqfn238) (GRID: grid.412017.1) (ISNI: 0000 0001 0266 8918); Department of Pharmacology, Zhongshan School of Medicine, Sun Yat-sen University, 510080, Guangzhou, China (ROR: https://ror.org/0064kty71) (GRID: grid.12981.33) (ISNI: 0000 0001 2360 039X)
2 Department of Pharmacology, Zhongshan School of Medicine, Sun Yat-sen University, 510080, Guangzhou, China (ROR: https://ror.org/0064kty71) (GRID: grid.12981.33) (ISNI: 0000 0001 2360 039X)
3 Department of Hepatobiliary Surgery, The First Affiliated Hospital, Sun Yat-sen University, 510700, Guangzhou, China (ROR: https://ror.org/0064kty71) (GRID: grid.12981.33) (ISNI: 0000 0001 2360 039X)
4 Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Disease, The Sixth Affiliated Hospital of Sun Yat-sen University, 510655, Guangzhou, China (ROR: https://ror.org/005pe1772) (GRID: grid.488525.6)
5 School of Medicine, Sun Yat-sen University, 510080, Guangzhou, China (ROR: https://ror.org/0064kty71) (GRID: grid.12981.33) (ISNI: 0000 0001 2360 039X)
6 Guangzhou Virotech Pharmaceutical Co., Ltd, 510663, Guangzhou, China (ROR: https://ror.org/03hkh9419) (GRID: grid.454193.e) (ISNI: 0000 0004 1789 3597)
7 Department of Pharmacology, School of Medicine, Jinan University, 510632, Guangzhou, China (ROR: https://ror.org/02xe5ns62) (GRID: grid.258164.c) (ISNI: 0000 0004 1790 3548); Institute of Medical Microbiology, Jinan University, 510632, Guangzhou, China (ROR: https://ror.org/02xe5ns62) (GRID: grid.258164.c) (ISNI: 0000 0004 1790 3548)
8 Department of Microbiology, Zhongshan School of Medicine, Sun Yat-sen University, 510080, Guangzhou, China (ROR: https://ror.org/0064kty71) (GRID: grid.12981.33) (ISNI: 0000 0001 2360 039X)
9 Department of Pharmacology, School of Medicine, Jinan University, 510632, Guangzhou, China (ROR: https://ror.org/02xe5ns62) (GRID: grid.258164.c) (ISNI: 0000 0004 1790 3548)
10 Department of Pharmacology, Zhongshan School of Medicine, Sun Yat-sen University, 510080, Guangzhou, China (ROR: https://ror.org/0064kty71) (GRID: grid.12981.33) (ISNI: 0000 0001 2360 039X); Department of Medical Statistics and Epidemiology, School of Public Health, Sun Yat-sen University, 510080, Guangzhou, China (ROR: https://ror.org/0064kty71) (GRID: grid.12981.33) (ISNI: 0000 0001 2360 039X)
1 Institute of Clinical Medicine, The First Affiliated Hospital, University of South China, 421001, Hengyang, China (ROR: https://ror.org/03mqfn238) (GRID: grid.412017.1) (ISNI: 0000 0001 0266 8918); Department of Pharmacology, Zhongshan School of Medicine, Sun Yat-sen University, 510080, Guangzhou, China (ROR: https://ror.org/0064kty71) (GRID: grid.12981.33) (ISNI: 0000 0001 2360 039X)
2 Department of Pharmacology, Zhongshan School of Medicine, Sun Yat-sen University, 510080, Guangzhou, China (ROR: https://ror.org/0064kty71) (GRID: grid.12981.33) (ISNI: 0000 0001 2360 039X)
3 Department of Hepatobiliary Surgery, The First Affiliated Hospital, Sun Yat-sen University, 510700, Guangzhou, China (ROR: https://ror.org/0064kty71) (GRID: grid.12981.33) (ISNI: 0000 0001 2360 039X)
4 Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Disease, The Sixth Affiliated Hospital of Sun Yat-sen University, 510655, Guangzhou, China (ROR: https://ror.org/005pe1772) (GRID: grid.488525.6)
5 School of Medicine, Sun Yat-sen University, 510080, Guangzhou, China (ROR: https://ror.org/0064kty71) (GRID: grid.12981.33) (ISNI: 0000 0001 2360 039X)
6 Guangzhou Virotech Pharmaceutical Co., Ltd, 510663, Guangzhou, China (ROR: https://ror.org/03hkh9419) (GRID: grid.454193.e) (ISNI: 0000 0004 1789 3597)
7 Department of Pharmacology, School of Medicine, Jinan University, 510632, Guangzhou, China (ROR: https://ror.org/02xe5ns62) (GRID: grid.258164.c) (ISNI: 0000 0004 1790 3548); Institute of Medical Microbiology, Jinan University, 510632, Guangzhou, China (ROR: https://ror.org/02xe5ns62) (GRID: grid.258164.c) (ISNI: 0000 0004 1790 3548)
8 Department of Microbiology, Zhongshan School of Medicine, Sun Yat-sen University, 510080, Guangzhou, China (ROR: https://ror.org/0064kty71) (GRID: grid.12981.33) (ISNI: 0000 0001 2360 039X)
9 Department of Pharmacology, School of Medicine, Jinan University, 510632, Guangzhou, China (ROR: https://ror.org/02xe5ns62) (GRID: grid.258164.c) (ISNI: 0000 0004 1790 3548)
10 Department of Pharmacology, Zhongshan School of Medicine, Sun Yat-sen University, 510080, Guangzhou, China (ROR: https://ror.org/0064kty71) (GRID: grid.12981.33) (ISNI: 0000 0001 2360 039X); Department of Medical Statistics and Epidemiology, School of Public Health, Sun Yat-sen University, 510080, Guangzhou, China (ROR: https://ror.org/0064kty71) (GRID: grid.12981.33) (ISNI: 0000 0001 2360 039X)
Nature Communications; London
Volume
16
Issue
1
Pages
9431
Number of pages
2
Publication year
2025
Publication date
2025
Section
Retraction Note
Place of publication
London
Country of publication
United States
Publication subject
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
Document type
Corrections/Retraction
Publication history
Online publication date
2025-10-24
Milestone dates
2025-10-15 (Registration)
Publication history
First posting date
24 Oct 2025
ProQuest document ID
3264792276
Document URL
https://www.proquest.com/scholarly-journals/retraction-note-dna-pk-inhibition-synergizes-with/docview/3264792276/se-2?accountid=208611
Copyright
© The Author(s) 2025. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Last updated
2025-10-31